(RTTNews) - European stocks closed on a weak note on Monday as worries about corporate earnings outlook, energy crisis following Russia turning off Nord Stream 1, and fresh Covid-19 curbs in China weighed on sentiment.
WASHINGTON (Reuters Breakingviews) - Now it’s Twitter’s turn to mess with Elon Musk. The Tesla boss on Friday ditched his $44 billion buyout of the social network after months of criticizing the firm. The social media company has now
What happened
Marijuana stocks are in retreat yet again today. Specifically, shares of Aurora Cannabis (NASDAQ: ACB) and Canopy Growth (NASDAQ: CGC) were both down by approximately 6.8%, while Sundial Growers (NASDAQ: SNDL) stock had fallen 5.5% as of 10:36 a.m. ET Monday morning
What happened
After reporting on July 8 that it was terminating a phase 2 clinical trial for its treatment aimed at metastatic squamous cell carcinoma of the head and neck (SCCHN), MacroGenics' (NASDAQ: MGNX) saw its stock drop by more than 10.8% on Monday as of 10:36 a.m. ET.
At Holdings Channel, we have reviewed the latest batch of the 21 most recent 13F filings for the 06/30/2022 reporting period, and noticed that Pfizer Inc (Symbol: PFE) was held by 16 of these funds. When hedge fund managers appear to be thinking alike, we find it is a good idea
What happened
Shares of content delivery network (CDN) Fastly (NYSE: FSLY) fell on Monday morning after receiving an analyst downgrade. It didn't help that the market was down sharply as well, providing further downward pressure. As of 11:20 a.m. ET, Fastly stock was down 14%.
Twitter's (NYSE: TWTR) stock tumbled to a four-month low on July 8 after Elon Musk formally terminated his $44 billion takeover bid for the company. In a Securities and Exchange Commission (SEC) filing, Musk's legal team said Twitter had breached the terms of the deal by making "
What happened
Netflix (NASDAQ: NFLX) shareholders lost ground to a falling market on Monday morning. Its shares had shed 4% by 11:30 a.m. compared to a 1.1% drop in the S&P 500. That decline added to the year's big losses for investors in the streaming video giant. Its shares
At Holdings Channel, we have reviewed the latest batch of the 22 most recent 13F filings for the 06/30/2022 reporting period, and noticed that JPMorgan Chase & Co (Symbol: JPM) was held by 13 of these funds. When hedge fund managers appear to be thinking alike, we find it is
What happened
Shares of Kinder Morgan (NYSE: KMI) gained 5.7% in the first half of 2022, according to data provided by S&P Global Market Intelligence. While that might not seem impressive, it was considering that the S&P 500 tumbled nearly 21% during that period.
President Joe Biden, marking the first major federal gun safety bill passed in three decades, said the United States is "awash in weapons of war" on Monday and renewed his call for assault weapons to be banned.
A company's own top management tend to have the best inside view into the business, so when company officers make major buys, investors are wise to take notice. Presumably the only reason an insider would take their hard-earned cash and use it to buy stock of their company in
In trading on Monday, the iShares U.S. Home Construction ETF is outperforming other ETFs, up about 0.4% on the day. Components of that ETF showing particular strength include shares of Taylor Morrison Home, up about 1.8% and shares of Green Brick Partners, up about 1.4% on the
(RTTNews) - Arcutis Biotherapeutics, Inc. (ARQT) announced Monday that Health Canada has accepted for review the New Drug Submission (NDS) for roflumilast cream 0.3% for the treatment of plaque psoriasis in adults and adolescents. The target action date is April 30, 2023.
(RTTNews) - Biopharmaceutical company Lipocine Inc. (LPCN) announced Monday that the U.S. Food and Drug Administration (FDA) has accepted the company's Investigational New Drug Application (IND) for its neuroactive steroid (NAS) candidate, LPCN 2101, as a potential treatment for
(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX) announced Monday that the company has entered into a definitive agreement under which Vertex will acquire privately-held biotechnology company ViaCyte for $320 million in cash.
Checked
8 minutes 8 seconds ago
This feed is responsible for generating the rss feed related to the topic META